Partnering Opportunities
Featured Innovations
Use of CXCR3 Inhibitors for Reducing and Preventing Preterm Birth and Pregnancy Complications
This technology utilizes methods and compositions related to reducing the risk of or preventing fetal wastage by administering CXCR3 inhibitors.
Therapy for Treatment of Myelodysplastic Syndrome (MDS)
IRAK1 is a drugable target for treatment of MDS, and IRAK1/BCL2 inhibitors synergistically co-treat MDS.
Partner with Us
View our innovation portfolio
Meet with our Team
BIO International | June 4-7
Contact Us
innovation.ventures@cchmc.org
Upcoming Events
Seminar with Industry:
Mike Myers, Senior Director Lilly Research Labs